نتائج البحث - "Forero-Torres A"

1

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ('METRIC'): a randomized multicenter study

المؤلفون: Rebecca G. Bagley, Denise A. Yardley, Volker Möbus, Abdel-Baset Halim, Rita Nanda, Gail S. Wright, Andres Forero-Torres, Thomas Hawthorne, Javier Cortes, Alberto J. Montero, Linda T. Vahdat, Kimberly L. Blackwell, Michelle E. Melisko, Melinda L. Telli, Yi He, Peter Schmid, Cynthia X. Ma, Christopher D. Turner

المساهمون: Institut Català de la Salut, [Vahdat LT] Weill Cornell Medicine, New York, NY, USA. [Schmid P] Center for Experimental Cancer Medicine, Barts Cancer Institute, London, UK. [Forero-Torres A] University of Alabama School of Medicine, Birmingham, AL, USA. [Blackwell K] Duke University Medical Center, Durham, NC, USA. [Telli ML] Stanford University School of Medicine, Stanford, CA, USA. [Melisko M] University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. [Cortes J] IOB Institute of Oncology, Quironsalud Group, Madrid & Barcelona. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: npj Breast Cancer, Vol 7, Iss 1, Pp 1-10 (2021)
Scientia
NPJ Breast Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Anthracycline, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Neutropenia, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Article, Capecitabine, 03 medical and health sciences, chemistry.chemical_compound, Breast cancer, 0302 clinical medicine, Metàstasi, Internal medicine, Clinical endpoint, medicine, Pharmacology (medical), Radiology, Nuclear Medicine and imaging, Triple-negative breast cancer, RC254-282, Cancer, GPNMB, business.industry, Neoplasms::Neoplastic Processes::Neoplasm Metastasis [DISEASES], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, neoplasias::neoplasias por localización::neoplasias de la mama::neoplasias de mama triple negativos [ENFERMEDADES], 030104 developmental biology, chemistry, neoplasias::procesos neoplásicos::metástasis neoplásica [ENFERMEDADES], 030220 oncology & carcinogenesis, Mama - Càncer - Tractament, Neoplasms::Neoplasms by Site::Breast Neoplasms::Triple Negative Breast Neoplasms [DISEASES], Avaluació de resultats (Assistència sanitària), business, Glembatumumab vedotin, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ba4d4292b16f0be2f40ca88020f4d3Test
https://doaj.org/article/17180d15d53a444b97cb83ce78fb7480Test

2

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

المؤلفون: Denise M. Wolf, Jane Perlmutter, Judy C. Boughey, A. Jo Chien, Meredith Buxton, Gillian L. Hirst, Douglas Yee, Angela DeMichele, Andres Forero-Torres, Scott M. Berry, Erin D. Ellis, Anthony D. Elias, Julia Wulfkuhle, Michael Alvarado, Christina Yau, Stacy L. Moulder, Nola M. Hylton, Rita Nanda, Amy Wilson, Adam Asare, Debu Tripathy, Claudine Isaacs, Melissa Paoloni, Rosa I. Gallagher, Laura J. Esserman, Richard Schwab, W. Fraser Symmans, Cheryl Ewing, Laura J. van't Veer, Jeffrey B. Matthews, Teresa Helsten, Julia L. Clennell, Barbara Haley, Emanuel F. Petricoin, Katherine Steeg, Smita Asare, Ashish Sanil, Rachel L. Yung, Erin P. Crane, Erin Roesch, Hyo S. Han, Ruby Singhrao, Michelle E. Melisko, Hope S. Rugo, Kathy S. Albain, Donald A. Berry, Anne M. Wallace, Julie E. Lang, Amy S. Clark, Kathleen Kemmer, Lamorna Brown-Swigart

المصدر: Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature communications, vol 12, iss 1
Nature Communications

مصطلحات موضوعية: Oncology, Receptor, ErbB-2, General Physics and Astronomy, Ado-Trastuzumab Emtansine, chemistry.chemical_compound, Breast cancer, ErbB-2, Trastuzumab, Monoclonal, skin and connective tissue diseases, Humanized, Cancer, Multidisciplinary, Tumor, medicine.diagnostic_test, Middle Aged, Neoadjuvant Therapy, Paclitaxel, 6.1 Pharmaceuticals, Pertuzumab, medicine.drug, Receptor, Adult, medicine.medical_specialty, Cyclophosphamide, Science, Clinical Trials and Supportive Activities, Context (language use), Breast Neoplasms, Antibodies, Monoclonal, Humanized, Article, General Biochemistry, Genetics and Molecular Biology, Antibodies, Clinical Research, Internal medicine, Biopsy, Breast Cancer, Biomarkers, Tumor, medicine, Humans, Doxorubicin, Maytansine, neoplasms, Aged, business.industry, Evaluation of treatments and therapeutic interventions, General Chemistry, Translational research, medicine.disease, chemistry, business, Biomarkers

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59a35df0abba974813caa569553019c1Test
https://doaj.org/article/e6340916dac6476fac8b24ed5afd32c1Test

3

Economic burden of central nervous system metastases in human epidermal growth factor receptor 2–positive breast cancer

المؤلفون: Andres Forero-Torres, Joseph Feliciano, Naomi Rm Schwartz, Ali McBride, Vamshi Ruthwik Anupindi, Kendra DeBusk, Jason Yeaw

المصدر: Future Oncology. 17:3457-3463

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Databases, Factual, Receptor, ErbB-2, Central nervous system, Breast Neoplasms, Financial Stress, Central Nervous System Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Matched cohort, Internal medicine, medicine, Humans, In patient, Claims database, Human Epidermal Growth Factor Receptor 2, Retrospective Studies, business.industry, Health Care Costs, General Medicine, Middle Aged, Prognosis, medicine.disease, Combined Modality Therapy, Metastatic breast cancer, 030104 developmental biology, medicine.anatomical_structure, Case-Control Studies, 030220 oncology & carcinogenesis, Female, business, Resource utilization, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5d32039b7ca732a112cfdae09c99d40Test
https://doi.org/10.2217/fon-2020-1292Test

4

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer

المؤلفون: Edward P. Acosta, Jori E. May, Lisle Nabell, Eva Olariu, Andres Forero-Torres, Erica Stringer-Reasor, Dongquan Chen, Eddy S. Yang, Valerie Caterinicchia, Gabrielle B. Rocque, Carla I. Falkson, Christos Vaklavas, Deborah L. Della Manna, Yufeng Li

المصدر: Breast Cancer Research, Vol 23, Iss 1, Pp 1-12 (2021)
Breast Cancer Research : BCR

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, Synthetic lethality, Veliparib, medicine.medical_treatment, DNA repair, Pilot Projects, Triple Negative Breast Neoplasms, Lapatinib, lcsh:RC254-282, Targeted therapy, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Triple-negative breast cancer, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Neoplasm Metastasis, PARP inhibitors, 030304 developmental biology, Neoplasm Staging, 0303 health sciences, Taxane, business.industry, Cancer, Disease Management, Middle Aged, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Treatment Outcome, Tolerability, chemistry, 030220 oncology & carcinogenesis, Benzimidazoles, Female, Drug Monitoring, business, medicine.drug, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f9e960766b33cca430ea79e295d5f6cTest
https://doaj.org/article/73538d58c45c449bae948e795b13f120Test

5

Use of 18F-FDG PET/CT as an Initial Staging Procedure for Stage II–III Breast Cancer: A Multicenter Value Analysis

المؤلفون: Heather Beckwith, Flora Varghese, Andres Forero-Torres, Michelle E. Melisko, Robert R. Flavell, Claudine Isaacs, Laura J. Esserman, Colby J. Hyland, Christina Yau, William Varnado, Gillian L. Hirst, A. Jo Chien, Douglas Yee, Katia E. Khoury

المصدر: Journal of the National Comprehensive Cancer Network. 18:1510-1517

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7c6bbbcc30e168d8d276eb7ba46c43aeTest
https://doi.org/10.6004/jnccn.2020.7598Test

6

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer:a multicentre pooled analysis of 5161 patients

المؤلفون: Christina Yau, Marie Osdoit, Marieke van der Noordaa, Sonal Shad, Jane Wei, Diane de Croze, Anne-Sophie Hamy, Marick Laé, Fabien Reyal, Gabe S Sonke, Tessa G Steenbruggen, Maartje van Seijen, Jelle Wesseling, Miguel Martín, Maria del Monte-Millán, Sara López-Tarruella, Judy C Boughey, Matthew P Goetz, Tanya Hoskin, Rebekah Gould, Vicente Valero, Stephen B Edge, Jean E Abraham, John M S Bartlett, Carlos Caldas, Janet Dunn, Helena Earl, Larry Hayward, Louise Hiller, Elena Provenzano, Stephen-John Sammut, Jeremy S Thomas, David Cameron, Ashley Graham, Peter Hall, Lorna Mackintosh, Fang Fan, Andrew K Godwin, Kelsey Schwensen, Priyanka Sharma, Angela M DeMichele, Kimberly Cole, Lajos Pusztai, Mi-Ok Kim, Laura J van 't Veer, Laura J Esserman, W Fraser Symmans, Kathi Adamson, Kathy S. Albain, Adam L. Asare, Smita M. Asare, Ron Balassanian, Heather Beckwith, Scott M. Berry, Donald A. Berry, Judy C. Boughey, Meredith B. Buxton, Yunn-Yi Chen, Beiyun Chen, A. Jo Chien, Stephen Y. Chui, Amy S. Clark, Julia L. Clennell, Brian Datnow, Angela M. DeMichele, Xiuzhen Duan, Kirsten K. Edmiston, Anthony D. Elias, Erin D. Ellis, Laura L. Esserman, David M. Euhus, Oluwole Fadare, Michael D Feldman, Andres Forero-Torres, Barbara B. Haley, Hyo S. Han, Shuko Harada, Patricia Haugen, Teresa Helsten, Gillian L. Hirst, Nola M. Hylton, Claudine Isaacs, Kathleen Kemmer, Qamar J. Khan, Laila Khazai, Molly E. Klein, Gregor Krings, Julie E. Lang, Lauren G. LeBeau, Brian Leyland-Jones, Minetta C. Liu, Shelly Lo, Janice Lu, Anthony Magliocco, Jeffrey B. Matthews, Michelle E. Melisko, Paulette Mhawech-Fauceglia, Stacy L. Moulder, Rashmi K. Murthy, Rita Nanda, Donald W. Northfelt, Idris T. Ocal, Olufunmilayo Olopade, Stefan Pambuccian, Melissa Paoloni, John W. Park, Barbara A. Parker, Jane Perlmutter, Garry Peterson, Mara Rendi, Hope S. Rugo, Sunati Sahoo, Sharon Sams, Ashish Sanil, Husain Sattar, Richard B. Schwab, Ruby Singhrao, Katherine Steeg, Erica Stringer-Reasor, W. Fraser Symmans, Ossama Tawfik, Debasish Tripathy, Megan L. Troxell, Laura J. van't Veer, Sara J. Venters, Tuyethoa Vinh, Rebecca K. Viscusi, Anne M. Wallace, Shi Wei, Amy Wilson, Douglas Yee, Jay C. Zeck

المساهمون: Pathology

المصدر: I-SPY 2 Trial Consortium 2022, ' Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer : a multicentre pooled analysis of 5161 patients ', The Lancet Oncology, vol. 23, no. 1, pp. 149-160 . https://doi.org/10.1016/S1470-2045Test(21)00589-1
The Lancet. Oncology, vol 23, iss 1
The Lancet Oncology, 23(1), 149-160. Lancet Publishing Group